TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
38 hedge funds and large institutions have $119M invested in Talis Biomedical Corporation Common Stock in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
38
Holding in Top 10
–
Calls
$2.14M
Puts
$342K
Top Buyers
| 1 | +$281K | |
| 2 | +$279K | |
| 3 | +$256K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$204K |
| 5 |
PP
PDT Partners
New York
|
+$188K |
Top Sellers
| 1 | -$4.01M | |
| 2 | -$1.1M | |
| 3 | -$798K | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$514K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$371K |